Comparative tolerability of targeted therapies in pulmonary hypertension

Comparative tolerability of targeted therapies in pulmonary hypertension

Introduction The objective of this study was to estimate the safety profile of pulmonary hypertension-specific therapies using placebo-controlled and active comparator trials. Material and methods The search corpus comprised Medline, Scopus, Embase and Clinical Trials databases. A systematic review...

Full description

Bibliographic Details
Main Authors:	Magdalena Jasińska-Stroschein, Karolina Stawarczyk, Anna Stępień, Daria Orszulak-Michalak
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-06-01
Series:	Archives of Medical Science
Subjects:	pulmonary arterial hypertension targeted drugs adverse drug reactions meta-analysis
Online Access:	https://www.archivesofmedicalscience.com/Comparative-tolerability-of-targeted-therapies-in-pulmonary-hypertension,114130,0,2.html

Similar Items

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
by: Naoyuki Otani, et al.
Published: (2022-10-01)

An updated review of experimental rodent models of pulmonary hypertension and left heart disease
by: Magdalena Jasińska-Stroschein
Published: (2024-01-01)

Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease
by: Hiroki Nakayama, et al.
Published: (2023-07-01)

Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials
by: Gao XF, et al.
Published: (2017-05-01)

Insights into Endothelin Receptors in Pulmonary Hypertension
by: Ruiqi Liu, et al.
Published: (2023-06-01)

New Drugs and Therapies in Pulmonary Arterial Hypertension
by: Aangi J. Shah, et al.
Published: (2023-03-01)

Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis
by: Sakayori M, et al.
Published: (2019-07-01)

Animal Models of Pulmonary Arterial Hypertension and Their Application in Drug Research
by: YU Jiahui, et al.
Published: (2023-08-01)

Pulmonary Arterial Hypertension and Adverse Outcomes after Kidney Transplantation: A Systematic Review and Meta-Analysis
by: Crischentian Brinza, et al.
Published: (2022-03-01)

Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia
by: Junjing Su, et al.
Published: (2017-07-01)

Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis
by: Ruihua Zhang, et al.
Published: (2022-11-01)

Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2022-06-01)

The efficacy of the treat-repair-treat strategy for severe pulmonary arterial hypertension associated with congenital heart disease: a meta-analysis
by: Zhiyuan Wang, et al.
Published: (2023-11-01)

MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
by: Łukasz Wołowiec, et al.
Published: (2023-06-01)

Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension
by: Zolty R
Published: (2021-08-01)

The prognostic significance of the alterations of pulmonary hemodynamics in patients with pulmonary arterial hypertension: a meta-regression analysis of randomized controlled trials
by: Shih-Hsien Sung, et al.
Published: (2021-10-01)

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
by: Victor Segura-Ibarra, et al.
Published: (2018-07-01)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
by: Jiang-Shan Tan, et al.
Published: (2022-03-01)

Pharmacist Interventions in Minimizing Drug Related Problems in Diabetes With Co-Existing Hypertension: A Five-Year Overview and Ground Report From India
by: Ian Osoro, et al.
Published: (2023-04-01)

Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes
by: Taylor Beckmann, et al.
Published: (2022-10-01)

Drug-induced arterial hypertension
by: Olga D Ostroumova, et al.
Published: (2019-06-01)

An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension
by: Vinit Agnihotri, et al.
Published: (2022-05-01)

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
by: Tomasz Stącel, et al.
Published: (2021-07-01)

Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
by: Luis Regalado, BS, MSc, et al.
Published: (2022-01-01)

Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis
by: Pengwei Wang, et al.
Published: (2022-02-01)

Comparative Study on Effects of 2% Lidocaine Hydrochloride with Adrenaline (1:200000) on Blood Pressure Among Controlled Hypertensive and Non-hypertensive Patients During Dental Anesthesia
by: Lujaw Ratna Tuladhar, et al.
Published: (2021-05-01)

An Adolescent Patient With Idiopathic Pulmonary Arterial Hypertension Weaned Off Intravenous Epoprostenol Following Treatment With Selexipag: A Case Report
by: Ayako Chida-Nagai, et al.
Published: (2022-06-01)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
by: Sarah Beshay, et al.
Published: (2022-01-01)

Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
by: B. Degano, et al.
Published: (2009-09-01)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension
by: Majdy M. Idrees, et al.
Published: (2014-01-01)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023-07-01)

Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America
by: Mauricio Orozco‐Levi, et al.
Published: (2022-01-01)

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study
by: Georges Hatem, et al.
Published: (2023-07-01)

Cardiovascular magnetic resonance in pulmonary hypertension
by: Bradlow William M, et al.
Published: (2012-01-01)

Rehabilitation in patients with pulmonary arterial hypertension
by: Stephan Keusch, et al.
Published: (2017-07-01)

Pulmonary arterial hypertension: diagnosis and treatment
by: Marcin Sadowski, et al.
Published: (2013-10-01)

Pulmonary Hypertension in Pregnancy: Challenges and Solutions
by: Afify H, et al.
Published: (2022-04-01)

Pulmonary hypertension and pulmonary artery dissection
by: Ricardo de Amorim Corrêa, et al.
Published: (2013-04-01)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
by: Rubin Tan, et al.
Published: (2022-11-01)